ATE376056T1 - Mn gen und protein - Google Patents

Mn gen und protein

Info

Publication number
ATE376056T1
ATE376056T1 AT99955151T AT99955151T ATE376056T1 AT E376056 T1 ATE376056 T1 AT E376056T1 AT 99955151 T AT99955151 T AT 99955151T AT 99955151 T AT99955151 T AT 99955151T AT E376056 T1 ATE376056 T1 AT E376056T1
Authority
AT
Austria
Prior art keywords
protein
proteins
polypeptides
disclosed
encode
Prior art date
Application number
AT99955151T
Other languages
English (en)
Inventor
Jan Zavada
Silvia Pastorekova
Jaromir Pastorek
Original Assignee
Inst Virology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/177,776 external-priority patent/US6297051B1/en
Priority claimed from US09/178,115 external-priority patent/US6297041B1/en
Application filed by Inst Virology filed Critical Inst Virology
Application granted granted Critical
Publication of ATE376056T1 publication Critical patent/ATE376056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99955151T 1998-10-23 1999-10-22 Mn gen und protein ATE376056T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/177,776 US6297051B1 (en) 1997-01-24 1998-10-23 MN gene and protein
US09/178,115 US6297041B1 (en) 1992-03-11 1998-10-23 MN gene and protein

Publications (1)

Publication Number Publication Date
ATE376056T1 true ATE376056T1 (de) 2007-11-15

Family

ID=26873634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99955151T ATE376056T1 (de) 1998-10-23 1999-10-22 Mn gen und protein

Country Status (11)

Country Link
EP (2) EP1123387B1 (de)
JP (3) JP3910798B2 (de)
AT (1) ATE376056T1 (de)
AU (1) AU758957C (de)
CA (1) CA2347649C (de)
CY (1) CY1107268T1 (de)
DE (1) DE69937364T2 (de)
DK (1) DK1123387T3 (de)
ES (1) ES2296412T3 (de)
NO (1) NO328884B1 (de)
WO (1) WO2000024913A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US20040077081A1 (en) 2001-02-07 2004-04-22 Egbert Oosterwijk Hybridoma cell line g250 and its use for producing monoclonal antibodies
AR036833A1 (es) * 2001-10-18 2004-10-06 Bayer Corp Anticuerpos humanos que se unen a mn y tienen actividad neutralizante de la adhesion celular.
US7910549B2 (en) * 2001-12-13 2011-03-22 Institute Of Virology Of The Slovak Academy Of Sciences MN gene and protein
SI1487972T1 (sl) 2002-02-21 2016-03-31 Institute Of Virology Slovak Academy Of Sciences Monoklonska protitelesa, specifična za MN/CA IX, proizvedena iz MN/CA IX deficientnih miši, in postopki uporabe
HUE026218T2 (en) 2002-02-21 2016-05-30 Inst Virology MN / CA IX-Specific Monoclonal Antibodies and Methods for MN / CA IX Deficient Mice
AU2003223186A1 (en) * 2002-05-23 2004-01-23 Bayer Healthcare SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2
EP2357005A1 (de) 2002-07-01 2011-08-17 Wilex AG Zusammensetzungen von CG250 und IL-2 oder von CG250 und IFN-alpha zur Krebsbehandlung des Nierenzellkarzinoms
AU2003268180A1 (en) * 2002-08-23 2004-03-11 Chiron Corporation Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
CA2506983C (en) 2002-11-26 2010-03-30 Institute Of Virology Ca ix-specific inhibitors
EP1673630A4 (de) * 2003-10-16 2009-04-29 Inst Virology Mn/ca ix und krebsprognose
JP4426621B2 (ja) 2004-05-04 2010-03-03 バイエル ヘルスケア エルエルシー Ｍｎ／ｃａ ｉｘ／ｃａ９及び腎臓癌の予後診断
US7820159B2 (en) 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
US8399625B1 (en) * 2009-06-25 2013-03-19 ESBATech, an Alcon Biomedical Research Unit, LLC Acceptor framework for CDR grafting
AU2014220705C1 (en) 2013-02-22 2018-10-18 Wilex Ag CAIX stratification based cancer treatment
CZ2014527A3 (cs) * 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034650A2 (en) * 1994-06-15 1995-12-21 Ciba Corning Diagnostics Corp. Mn gene and protein
US6329501B1 (en) * 1997-05-29 2001-12-11 Auburn University Methods and compositions for targeting compounds to muscle
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes

Also Published As

Publication number Publication date
DE69937364T2 (de) 2008-07-17
NO20011926L (no) 2001-06-19
ES2296412T3 (es) 2008-04-16
WO2000024913A2 (en) 2000-05-04
EP1123387A2 (de) 2001-08-16
AU1132300A (en) 2000-05-15
JP2002528085A (ja) 2002-09-03
CY1107268T1 (el) 2012-11-21
JP2007145843A (ja) 2007-06-14
JP4044597B2 (ja) 2008-02-06
JP3910798B2 (ja) 2007-04-25
AU758957C (en) 2004-08-12
EP1123387B1 (de) 2007-10-17
AU758957B2 (en) 2003-04-03
EP1832653A1 (de) 2007-09-12
JP4488373B2 (ja) 2010-06-23
DE69937364D1 (de) 2007-11-29
NO20011926D0 (no) 2001-04-19
JP2008069151A (ja) 2008-03-27
CA2347649A1 (en) 2000-05-04
CA2347649C (en) 2012-03-13
DK1123387T3 (da) 2008-02-25
NO328884B1 (no) 2010-06-07
WO2000024913A3 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
CY1107268T1 (el) Μν γονιδιο και πρωτεϊνη
NO20100685L (no) Polypeptid samt anvendelse derav og peptidkompleks, og fremgangsmate for identifisering av et organisk eller uorganisk molekyl
ATE87659T1 (de) Bindungsmolekuele mit einzelpolypeptidkette.
NO990086D0 (no) Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
ATE537258T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
DK1294876T3 (da) EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse
NO2007015I1 (no) Ranibizumab
CA2347131A1 (en) Modified peptides as therapeutic agents
NO994870L (no) Humaniserte antistoffer og metoder for å danne humaniserte antistoffer
ATE541935T1 (de) Wachstumshormon fusionprotein
ATE446510T1 (de) Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine
WO2002005843A3 (en) Human rrp sequences and methods of use
DE60313743D1 (de) Mit influenzavirus-hämagglutinin und influenza m2 pseudotypisierte retrovirusvektoren zur zuführung von genen
DK0789763T3 (da) ICAM-4-materialer og fremgangsmåder
EP0603672A3 (de) Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung.
DK1105485T3 (da) Human IL-1-epsilon-DNA og polypeptider
SE0003573D0 (sv) Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
DK1233980T3 (da) Nukleinsyremolekyle, omfattende en nukleinsyresekvens, der koder for et hæmocyanin, og mindst en intronsekvens
ATE440110T1 (de) Zusammensetzungen und verfahren zur behandlung der polyzystischen nierenkrankheit
HOROWITZ CYCLIC-AMP-DEPENDENT PROTEIN KINASE REGULATION OF SPERM MOTILITY.
DK1191101T3 (da) PRO241 polypeptider og nucleinsyre kodende herfor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1123387

Country of ref document: EP